Search Results 591-600 of 18350 for Lactation

  1. Extended Access of Momelotinib in Adults With Myelofibrosis - Mayo Clinic

    Pregnant or lactating females. Presence of ≥ Grade 3 (CTCAE Version 4.03) peripheral neuropathy. Known positive status for human immunodeficiency virus ...

  2. Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis - Mayo Clinic

    Male, or non-pregnant, non-lactating female who agrees to comply with any applicable contraceptive requirements of the protocol or females of non-childbearing ...

  3. A Study Of Oral Levosimendan In Pulmonary Hypertension With Heart Failure With Preserved Left Ventricular Ejection Fraction - Mayo Clinic

    Female patients of childbearing potential must have a negative pregnancy test result at the Enrollment visit and must not be pregnant, lactating, or ...

  4. Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension - Mayo Clinic

    If female: planned or known pregnancy, positive urine or serum pregnancy test, or lactating/breastfeeding; Previous treatment with emricasan or active ...

  5. Colonoscopy - Doctors & Departments - Mayo Clinic

    Guidelines for endoscopy in pregnant and lactating women. Gastrointestinal Endoscopy. 2012; doi:10.1016/j.gie.2012.02.029. Can you have a colonoscopy when ...

  6. A Study to Evaluate the Safety and Effectiveness of RM-131 Administered to Patients with Vomiting Symptoms and Moderate to Severe Diabetes Caused Paralysis of the Stomach - Mayo Clinic

    If female, has a negative serum or urine pregnancy test and is not lactating; For females able to bear children, a hormonal (i.e., oral, implantable, or ...

  7. A Study To Test The Addition Of The Drug Cabozantinib To Chemotherapy In Patients With Newly Diagnosed Osteosarcoma - Mayo Clinic

    Lactating females who plan to breastfeed their infants. Sexually active patients of reproductive potential who have not agreed to use an effective ...

  8. A Study to Evaluate CC-98633 to Treat Subjects with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    Pregnant or nursing (lactating) women. Previous SARS-CoV-2 infection within 10 days for mild or asymptomatic infections or 20 days for severe/critical ...

  9. A Study to Evaluate the Effectiveness of Merimepodib in Adult Patients with Advanced COVID-1 - Mayo Clinic

    Pregnant or lactating. Any condition which, in the opinion of the Investigator, places the subject at unacceptable risk if he/she were to participate in the ...

  10. Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) - Mayo Clinic

    * Must agree to provide protocol specified samples for biomarker analyses. Exclusion Criteria: * Pregnant or lactating women * diagnosis of ocular or ...